{
    "organizations": [],
    "uuid": "1c39e02de9e3a76f2119e5ad2032c2ed3735cb1f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biodelivery-sciences-announces-pri/brief-biodelivery-sciences-announces-pricing-of-50-million-equity-financing-idUSASC0A2RX",
    "ord_in_thread": 0,
    "title": "BRIEF-BioDelivery Sciences Announces Pricing Of $50 Million Equity Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - BioDelivery Sciences International Inc :\n* BIODELIVERY SCIENCES ANNOUNCES PRICING OF $50 MILLION EQUITY FINANCING\n* BIODELIVERY SCIENCES INTERNATIONAL INC - SERIES B STOCK IS BEING SOLD FOR $10,000 PER SHARE\n* BIODELIVERY SCIENCES - EACH SHARE OF SERIES B STOCK WILL BE CONVERTIBLE INTO NUMBER OF SHARES OF COMMON STOCK DETERMINED BY DIVIDING $10,000 BY $1.80 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-17T20:38:00.000+03:00",
    "crawled": "2018-05-18T19:41:33.041+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "biodelivery",
        "science",
        "international",
        "inc",
        "biodelivery",
        "science",
        "announces",
        "pricing",
        "million",
        "equity",
        "financing",
        "biodelivery",
        "science",
        "international",
        "inc",
        "series",
        "b",
        "stock",
        "sold",
        "per",
        "share",
        "biodelivery",
        "science",
        "share",
        "series",
        "b",
        "stock",
        "convertible",
        "number",
        "share",
        "common",
        "stock",
        "determined",
        "dividing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}